Compare Illinois Tool Works Inc. (ITW) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illinois Tool Works Inc. vs Zimmer Biomet Holdings Inc — how do they compare? Illinois Tool Works Inc. trades at $271.88 (market cap $78.17B), while Zimmer Biomet Holdings Inc trades at $90.03 (market cap $17.36B). The key difference: Illinois Tool Works Inc. is far larger — about 4.5× Zimmer Biomet Holdings Inc's market cap, and Illinois Tool Works Inc. pays the higher dividend (2.37%). Which is the better fit depends on your goals.
| ITW | ZBH | |
|---|---|---|
Market Cap | $78.17B | $17.36B |
Sector | Industrials | Health |
52-Week High | $299.60 | $107.71 |
52-Week Low | $241.07 | $79.58 |
Enterprise Value | $86.49B | $24.40B |
Dividend Yield | 2.37% | 1.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illinois Tool Works Inc.
Illinois Tool Works is a diversified global manufacturer that produces specialized industrial equipment, consumables, and related services. The firm operates 87 global divisions through seven distinct operating segments: automotive OEM, construction products, food equipment, specialty products, test/measurement and electronics, polymers and fluids, and welding. About half of its revenue comes from its operations in North America, with the remainder originating from international markets. ITW takes a bottom-up and decentralized approach to portfolio management, with the exception that each segment must apply its 80/20 operating process modeled on the Pareto principle.
Read more on ITW →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
